SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,570.35 -373.93
( -0.49%)

Global Indices

Nasdaq

52,794.59 -412.31
(-0.77%)

Dow Jones

7,653.60 -53.54
(-0.69%)

Hang Seng

64,415.54 -1,799.80
(-2.72%)

Nikkei 225

10,761.93 -27.35
(-0.25%)

Forex

USD-INR

95.24 -0.24
(-0.25%)

EUR-INR

110.49 -0.08
(-0.07%)

GBP-INR

128.99 -0.20
(-0.15%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

585.7422969

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

11.22

212.81

EPS(TTM)

Face Value()

Div & Yield %

53.11

0.34

Back

epigral ltd

PSP Projects consolidated net profit rises 4266.67% in the June 2026 quarter

Jul 30,2026

Net profit of PSP Projects rose 4266.67% to Rs 18.34 crore in the quarter ended June 2026 as against Rs 0.42 crore during the previous quarter ended June 2025. Sales rose 64.84% to Rs 853.47 crore in the quarter ended June 2026 as against Rs 517.76 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	853.47	517.76	65
OPM %	6.42	4.79	-
PBDT	51.31	17.62	191
PBT	28.25	0.73	3770
NP	18.34	0.42	4267

76,570.35 -373.93 ( -0.49%)

52,794.59 -412.31 (-0.77%)

7,653.60 -53.54 (-0.69%)

64,415.54 -1,799.80 (-2.72%)

10,761.93 -27.35 (-0.25%)

95.24 -0.24 (-0.25%)

110.49 -0.08 (-0.07%)

128.99 -0.20 (-0.15%)

0.60 0.00 (-0.03%)